Drug Class
integrin receptor antagonist
Type
brand
Active Ingredient
vedolizumab
📋Overview
Entyvio is a biologic medication that targets specific proteins involved in the immune system. It is primarily associated with chronic inflammatory conditions of the digestive tract, such as ulcerative colitis and Crohn's disease. By modulating immune responses in the gut, Entyvio helps manage symptoms related to these disorders. Its use is generally reserved for cases where other therapies have not been effective.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Entyvio
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.